Translation of the National Institutes of Health Diabetes Prevention Program in African American churches. (Q46682464)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Translation of the National Institutes of Health Diabetes Prevention Program in African American churches (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

John M Boltri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Monique Davis-Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Ike S Okosun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

J Paul Seale

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Barbara Foster

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Medical Association

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

194-202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Economic costs of diabetes in the US in 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Race, rural residence, and control of diabetes and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

The Diabetes Prevention Program (DPP): description of lifestyle intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

High-risk individuals' willingness to pay for diabetes risk-reduction programs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Translation research for chronic disease: the case of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Considerations for diabetes translational research in real-world settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Translating research to practice: lessons learned, areas for improvement, and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Church-based education: an outreach program for African Americans with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Implementation and evaluation of church-based health fairs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Fruit and vegetable consumption and prevention of cancer: the Black Churches United for Better Health project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Health programs in faith-based organizations: are they effective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Research expectations among African American church leaders in the PRAISE! project: a randomized trial guided by community-based participatory research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Trust, benefit, satisfaction, and burden: a randomized controlled trial to reduce cancer risk through African-American churches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

The characteristics of northern black churches with community health outreach programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Body and soul. A dietary intervention conducted through African-American churches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

A trial of church-based smoking cessation interventions for rural African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Project Joy: faith based cardiovascular health promotion for African American women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Performance of recommended screening tests for undiagnosed diabetes and dysglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

Effectiveness of diabetes mellitus screening recommendations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930301-1

10.1016/S0027-9684(15)30301-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671523%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference